One-month qRT-PCR BCR::ABL1 transcript threshold to predict early recurrence in chronic phase CML patients attempting first treatment free remission

Eur J Haematol. 2023 Dec;111(6):970-972. doi: 10.1111/ejh.14085. Epub 2023 Aug 16.
No abstract available

Publication types

  • Letter

MeSH terms

  • Fusion Proteins, bcr-abl / genetics
  • Humans
  • Imatinib Mesylate / therapeutic use
  • Leukemia, Myeloid, Chronic-Phase*
  • Polymerase Chain Reaction
  • Protein Kinase Inhibitors / therapeutic use

Substances

  • Imatinib Mesylate
  • Fusion Proteins, bcr-abl
  • Protein Kinase Inhibitors

Grants and funding